MEDP (Medpace Holdings) Other Operating Expense : $29 Mil (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Other Operating Expense?

Medpace Holdings's Other Operating Expense for the three months ended in Sep. 2024 was $8 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was $29 Mil.

Medpace Holdings's quarterly Other Operating Expense increased from Mar. 2024 ($7 Mil) to Jun. 2024 ($7 Mil) and increased from Jun. 2024 ($7 Mil) to Sep. 2024 ($8 Mil).

Medpace Holdings's annual Other Operating Expense increased from Dec. 2021 ($21 Mil) to Dec. 2022 ($22 Mil) and increased from Dec. 2022 ($22 Mil) to Dec. 2023 ($26 Mil).

Medpace Holdings Other Operating Expense Historical Data

The historical data trend for Medpace Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Other Operating Expense Chart

Medpace Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

23.19

19.53

21.12

22.34

26.33

Medpace Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Operating Expense	Get a 7-Day Free Trial															6.88	6.97	6.99	7.23	7.52

Medpace Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $29 Mil.

Medpace Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (NAS:MEDP) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MEDP:Mexico 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Executives

Robert O. Kraft	director	ONE CVS DRIVE, WOONSOCKET RI 02895
Susan E Burwig	officer: Exec. VP, Operations	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
August J. Troendle	director, 10 percent owner, officer: CEO	5375 MEDPACE WAY, CINCINNATI OH 45227
Ashley M. Keating	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Investors, Llc	10 percent owner	4620 WESLEY AVENUE, CINCINNATI OH 45212
Jesse J Geiger	officer: CFO & COO, Lab Operations	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Stephen P Ewald	officer: General Counsel & Corp. Secy.	C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227
Kevin M. Brady	officer: CFO & Treasurer	MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Femida H. Gwadry-sridhar	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Davenport Fred B Jr	director
Mccarthy Cornelius P. Iii	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Brian T Carley	director	C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227
Tom C King	director	5375 MEDPACE WAY, CINCINNATI OH 45227
Medpace Limited Partnership	10 percent owner	EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP
Cinven Capital Management (v) General Partner Ltd	10 percent owner	EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP